Regulatory Authorities role in Pharmacovigilance, Drug Safety and Clinical Trials


The aim of regulatory authorities is to protect the safety and rights of the subjects participating in a trial, and to safeguard that trials are adequately designed to meet scientifically sound objectives.
The regulatory authorities ensure compliances in various legal and regulatory aspects of a drug. Every country has its own regulatory authority, which is responsible to impose the rules and regulations and issue the guidelines to regulate drug development process, licensing, registration, manufacturing, marketing and labeling of medicinal products.

Please see below list of regulatory authorities and organizations recognized in particular countries. Click on the links to know more details about the specific regulatory authority.

List of Regulatory Authorities:

EMEA (European Union)
European medicines agency

USFDA (USA)
US Food and Drug administration

CDSCO (India)
Central Drugs Standard Control Organization (CDSCO)

MHRA(UK)
Medicines and Healthcare products Regulatory Agency

TGA(Australia)
Therapeutic Goods Administration

HEALTH CANADA (Canada)

MCC (South Africa)
Medicines Control Council

ANVISA (Brazil)
Agência Nacional de Vigilância Sanitária or National Health Surveillance Agency of Brazil

SFDA (China)            
State Food and Drug Administration

NAFDAC (Nigeria)
National Agency for Food and Drug Administration and Control

MEDSAFE (Newzeland)
Medicines and Medical Devices Safety Authority

MHLW (Japan)
Ministry of Health, Labour and Welfare

MCAZ (Zimbabwe)
Medicines Control Authority of Zimbabwe

PMDA (Japan)
Pharmaceuticals and Medical Devices Agency

SWISSMEDIC (Switzerland)
Swiss Agency for Therapeutic Products

KFDA(Korea)
Korea Food and Drug Administration

MoH (Sri Lanka)
Ministry of Health & Indigenous medicine




No comments: